Skye Bioscience

0 followers


Skye Bioscience (OTC: SKYE) is a biopharmaceutical company engineering proprietary cannabinoid derivatives to treat glaucoma and other diseases with significant unmet medical needs.

Industries

Employees

11-50

Links


Org chart

Collapse
Kaitlyn Arsenault
Chief Financial Officer
Tu Diep
Chief Development Officer
Chris Twitty
Chief Scientific Officer
Karam Takhar
VP, Corporate Development & Investor Relations

Board & advisors

Eduardo Muñoz
Scientific Advisor
Giovanni Appendino
Scientific Advisor
Jeffrey Goldberg
Clinical Advisor
Louis Pasquale
Clinical Advisor
Robert Ritch
Clinical Advisor